TrialJAMA oncology2023
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial.
Chad Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
108 papers cite itlatest 60 shown
this paperpooled ittrialcites it